Name | MEDFARMA, OOO |
|---|
INN | 4705054595 |
|---|
KPP | 470501001 |
|---|
OGRN | 1114705005964 |
|---|
OKPO | 90337045 |
|---|
Address | 188300, Leningradskaya Oblast', r-n Gatchinskiy, g Gatchina, ul Filippova, d. D. 1 |
|---|
Phone | Contact details |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 46.46 | Core activity | Wholesale of pharmaceutical goods | | 47.73 | Additional activity | Retailing drugs in specialized stores (pharmacies) |
Registration date | 16.08.2011 |
|---|
Registering department | MEZHRAYONNAYA INSPEKTSIYA FEDERAL'NOY NALOGOVOY SLUZHBY 7 PO LENINGRADSKOY OBLASTI |
|---|
|
MEDFARMA, OOO (Leningrad Oblast; INN 4705054595) was registered on 16 Aug 2011. The company's authorized capital as of July 1, 2012 was 12000 rub. Type of ownership of MEDFARMA, OOO - Limited liability companies. Form of ownership of MEDFARMA, OOO - Private property. Principal activities of MEDFARMA, OOO: wholesale of pharmaceutical goods (46.46), retailing drugs in specialized stores (pharmacies) (47.73). |
Economic indicators2023
Net profit (RAS) of MEDFARMA, OOO dropped in 2023 by 25.20% to 5.26 million RUB from 7.03 million RUB over the same period in 2022, the company informed. Revenue decreased in the accounting period by 2.56% to 768.07 million RUB from 788.26 million RUB in 2022; cost of goods sold decreased by 0.86% to 707.94 million RUB from 714.05 million RUB; sales loss made up 19.94 million RUB compared to sales profit of 1.86 million RUB. 2022
Net profit (RAS) of MEDFARMA, OOO grew over 2022 by 15.26% to 7.03 million RUB from 6.10 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 0.83% to 788.26 million RUB from 794.89 million RUB in 2021; cost of goods sold decreased by 3.01% to 714.05 million RUB from 736.20 million RUB; sales profit made up 1.86 million RUB compared to sales loss of 4.11 million RUB. 2021
Net profit (RAS) of MEDFARMA, OOO dropped in 2021 by 19.56% to 6.10 million RUB from 7.58 million RUB over the same period in 2020, the company informed. Revenue increased in the accounting period by 40.16% to 794.89 million RUB from 567.15 million RUB over 2020; cost of goods sold grew by 41.69% to 736.20 million RUB from 519.60 million RUB; sales loss made up 4.11 million RUB compared to sales profit of 1.09 million RUB. 2020
Net profit (RAS) of MEDFARMA, OOO grew over 2020 16.51 times to 7.58 million RUB from 459.00 thousand RUB over 2019, the company informed. Revenue increased in the accounting period 1.72 times to 567.15 million RUB from 329.59 million RUB over 2019; cost of goods sold grew 1.74 times to 519.60 million RUB from 297.77 million RUB; sales profit made up 1.09 million RUB compared to sales loss of 7.65 million RUB. 2019
Net profit (RAS) of MEDFARMA, OOO dropped in 2019 by 35.08% to 459.00 thousand RUB from 707.00 thousand RUB over the same period in 2018, the company informed. Revenue increased in the accounting period by 38.52% to 329.59 million RUB from 237.94 million RUB over 2018; cost of goods sold grew by 39.07% to 297.77 million RUB from 214.11 million RUB; sales loss grew by 29.62% to 7.65 million RUB from 5.90 million RUB. 2018
Net profit (RAS) of MEDFARMA, OOO grew over 2018 2.14 times to 707.00 thousand RUB from 331.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period 2.21 times to 237.94 million RUB from 107.89 million RUB over 2017; cost of goods sold grew 2.37 times to 214.11 million RUB from 90.17 million RUB; sales loss made up 5.90 million RUB compared to sales profit of 2.36 million RUB. 2017
Net profit (RAS) of MEDFARMA, OOO grew over 2017 1.63 times to 331.00 thousand RUB from 203.00 thousand RUB over 2016, the company informed. Revenue increased in the accounting period 1.58 times to 107.89 million RUB from 68.48 million RUB over 2016; cost of goods sold grew by 48.34% to 90.17 million RUB from 60.79 million RUB; sales profit went up 3.75 times to 2.36 million RUB from 628.00 thousand RUB. 2016
Net profit (RAS) of MEDFARMA, OOO grew over 2016 9.67 times to 203.00 thousand RUB from 21.00 thousand RUB over 2015, the company informed. Revenue increased in the accounting period 2.03 times to 68.48 million RUB from 33.77 million RUB over 2015; cost of goods sold grew 1.89 times to 60.79 million RUB from 32.12 million RUB; sales profit went up 2.88 times to 628.00 thousand RUB from 218.00 thousand RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|